Susquehanna International Group, LLP Bionomics Limited Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Bionomics Limited stock. As of the latest transaction made, Susquehanna International Group, LLP holds 34,138 shares of BNOX stock, worth $8,875. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,138Holding current value
$8,875% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BNOX
# of Institutions
10Shares Held
2.5MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY1.59MShares$414,1800.01% of portfolio
-
Lynx1 Capital Management LP San Juan, PR550KShares$142,9140.09% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct316KShares$82,1600.0% of portfolio
-
Rhumbline Advisers Boston, MA8.3KShares$2,1580.0% of portfolio
-
Morgan Stanley New York, NY894Shares$2320.0% of portfolio
About BIONOMICS LIMITED
- Ticker BNOX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,518,620
- Market Cap $1.95M
- Description
- Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has ...